L
Laurent Macle
Researcher at Montreal Heart Institute
Publications - 226
Citations - 16694
Laurent Macle is an academic researcher from Montreal Heart Institute. The author has contributed to research in topics: Atrial fibrillation & Catheter ablation. The author has an hindex of 53, co-authored 201 publications receiving 14008 citations. Previous affiliations of Laurent Macle include Université de Montréal & University of Adelaide.
Papers
More filters
Journal ArticleDOI
2017 HRS / EHRA / ECAS / APHRS / SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
Hugh Calkins,Gerhard Hindricks,Riccardo Cappato,Young Hoon Kim,Eduardo B. Saad,Luis Aguinaga,Joseph G. Akar,Vinay Badhwar,Josep Brugada,John Camm,Peng Sheng Chen,Shih Ann Chen,Mina K. Chung,Jens Cosedis Nielsen,Anne B. Curtis,D. Wyn Davies,John D. Day,Andre d'Avila,N. M. S. de Groot,Luigi Di Biase,Mattias Duytschaever,James R. Edgerton,Kenneth A. Ellenbogen,Patrick T. Ellinor,Sabine Ernst,Guilherme Fenelon,Edward P. Gerstenfeld,David E. Haines,Michel Haïssaguerre,Robert H. Helm,Elaine M. Hylek,Warren M. Jackman,José Jalife,José Jalife,Jonathan M. Kalman,Josef Kautzner,Hans Kottkamp,Karl Heinz Kuck,Koichiro Kumagai,Richard Lee,Thorsten Lewalter,Bruce D. Lindsay,Laurent Macle,Moussa Mansour,Francis E. Marchlinski,Gregory F. Michaud,Hiroshi Nakagawa,Andrea Natale,Stanley Nattel,Ken Okumura,Douglas L. Packer,Evgeny Pokushalov,Matthew R. Reynolds,Prashanthan Sanders,Mauricio Scanavacca,Richard J. Schilling,Claudio Tondo,Hsuan Ming Tsao,Atul Verma,David J. Wilber,Teiichi Yamane +60 more
TL;DR: This 2017 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a writing group, convened by these five international societies.
Journal ArticleDOI
Approaches to Catheter Ablation for Persistent Atrial Fibrillation
Atul Verma,Chen-yang Jiang,Timothy R. Betts,Jian Chen,I. Deisenhofer,Roberto Mantovan,Laurent Macle,Carlos A. Morillo,Wilhelm Haverkamp,Rukshen Weerasooriya,Jean-Paul Albenque,Stefano Nardi,Endrj Menardi,Paul Novak,Prashanthan Sanders +14 more
TL;DR: Among patients with persistent atrial fibrillation, there was no reduction in the rate of recurrent atrialfibrillation when either linear ablation or ablation of complex fractionated electrograms was performed in addition to pulmonary-vein isolation.
Journal ArticleDOI
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial
David J. Wilber,Carlo Pappone,Petr Neuzil,Angelo Amato Vincenzo de Paola,Frank Marchlinski,Andrea Natale,Laurent Macle,Emile G. Daoud,Hugh Calkins,Burr Hall,Vivek Y. Reddy,Giuseppe Augello,Matthew R. Reynolds,Chandan Vinekar,Christine Y. Liu,Scott M. Berry,Donald A. Berry +16 more
TL;DR: Among patients with paroxysmal AF who had not responded to at least 1 antiarrhythmic drug, the use of catheter ablation compared with ADT resulted in a longer time to treatment failure during the 9-month follow-up period.
Journal ArticleDOI
Catheter Ablation for Atrial Fibrillation Are Results Maintained at 5 Years of Follow-Up?
Rukshen Weerasooriya,Paul Khairy,Jean Litalien,Laurent Macle,Mélèze Hocini,Frederic Sacher,Nicolas Lellouche,Sébastien Knecht,Matthew Wright,Isabelle Nault,Shinsuke Miyazaki,Christophe Scavée,Jacques Clémenty,Michel Haïssaguerre,Pierre Jaïs +14 more
TL;DR: In selected patients with AF, a catheter ablation strategy with repeat intervention as necessary provides acceptable long-term relief, and a slow but steady decline in arrhythmia-free survival is noted thereafter.
Journal ArticleDOI
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study
Pierre Jaïs,Bruno Cauchemez,Laurent Macle,Emile G. Daoud,Paul Khairy,Rajesh N. Subbiah,Mélèze Hocini,Fabrice Extramiana,Frederic Sacher,Pierre Bordachar,George Klein,Rukshen Weerasooriya,Jacques Clémenty,Michel Haïssaguerre +13 more
TL;DR: This randomized multicenter study demonstrates the superiority of catheter ablation over antiarrhythmic drugs in patients with AF with regard to maintenance of sinus rhythm and improvement in symptoms, exercise capacity, and quality of life.